Experts wanted to help prioritize cancer research at European level
Despite substantial progress made in cancer research to date, there is much about the disease that remains a mystery. The facts are in the figures. In 2020 alone, 1.3 million...
Category: Oncology
Leading Comprehensive Cancer Center in France, Centre Léon Bérard, Joins the TriNetX Network to Improve Access to Innovative Therapies for Its Patients
Lyon, France, September 9, 2022 – Centre Léon Bérard (CLB), a Comprehensive Cancer Center in Lyon and Rhône-Alpes has joined the TriNetX global health research network. The TriNetX Network is comprised...
Tempus Announces Three Abstracts Accepted For Presentation at the European Society for Medical Oncology Congress 2022
CHICAGO–(BUSINESS WIRE)–Tempus, a leader in artificial intelligence and precision medicine, today announced three abstracts were accepted for presentation at the European Society for Medical Oncology (ESMO) Congress 2022, which convenes...
FREENOME LAUNCHES ITS FIRST STUDY FOR THE DETECTION OF MULTIPLE CANCERS THAT PAIRS MULTIOMICS WITH REAL-WORLD DATA
– The company is pioneering a new approach for the development and improvement of its test platform by combining multiomics with real-world data – The Sanderson Study underscores Freenome’s commitment to...
Guardant Health Expands Strategic Collaboration With Merck KGaA, Darmstadt, Germany, to Help Accelerate Development of Precision Oncology Therapeutics
Agreement will leverage GuardantINFORM real-world evidence platform to advance development efforts for core cancer indications August 31, 2022 08:05 AM Eastern Daylight Time PALO ALTO, Calif.–(BUSINESS WIRE)–Guardant Health, Inc. (Nasdaq:...
Syapse and Genesis Research Combine Forces to Offer Real-World Evidence Services and Data to Oncology Innovators
SAN FRANCISCO, Aug. 31, 2022 (GLOBE NEWSWIRE) — Syapse®, a leading real-world evidence company dedicated to extinguishing the fear and burden of serious diseases by advancing real-world care, today announced that they...
AACR Cancer Progress Report 2022: Discovery Science Driving Clinical Breakthroughs
Please join the American Association for Cancer Research (AACR) for a briefing on Wednesday, September 21 (12 p.m. – 1:30 p.m. ET) at the National Press Club in Washington, D.C....
Science 37 and Syapse Partner to Enable Faster Patient Enrollment in Oncology Clinical Trials
Oncology patients and clinical research sponsors benefit from Syapse’s real-world data intelligence and Science 37’s agile trial operating system to help accelerate the identification and participation of eligible participants August...
BeiGene Announces Strategic Alliance with Ontada to Improve U.S. Community Oncology Care
Collaboration focuses on developing and implementing real-world research to drive patient access to cancer medicines August 15, 2022 07:00 AM Eastern Daylight Time CAMBRIDGE, Mass. & BASEL, Switzerland & BEIJING–(BUSINESS...
Initial Analysis of Tumor Profiling From a Prospective Study by Foundation Medicine, Flatiron Health and Genentech Demonstrates Value of Tissue and Liquid Comprehensive Genomic Profiling in Patients with Advanced Non-Small Cell Lung Cancer
The ongoing real-world Prospective Clinicogenomic (PCG) Study compares the clinical actionability of both tissue- and blood-based comprehensive genomic profiling to limited tissue testing in this patient population August 08, 2022...